Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX: RMDA)

RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	83.32	52.36	66.96	14	13.23	53.94
Short-Term Investments	227.28	260.9	361.86	468.01	469.35	464.89
Cash & Short-Term Investments	310.6	313.25	428.82	482.01	482.58	518.83
Cash Growth	-13.42%	-26.95%	-11.04%	-0.12%	-6.99%	8585.40%
Accounts Receivable	593.83	353.74	276.6	265.96	238.41	275.71
Other Receivables	0.03	72.16	22.6	25.2	33.11	12.39
Receivables	1,148	1,344	923.28	684.61	666.63	511.58
Inventory	493.09	303.26	348.41	259.4	305.48	214.07
Prepaid Expenses	386.56	2.21	2.83	0.99	0.91	1.45
Other Current Assets	93.84	60.33	55.14	48.64	40.98	33.32
Total Current Assets	2,432	2,023	1,758	1,476	1,497	1,279
Property, Plant & Equipment	594.39	606.05	556.98	554.99	538.16	483.45
Other Intangible Assets	565.45	589.27	457.57	389.66	214.57	104.65
Total Assets	3,592	3,218	2,773	2,420	2,249	1,867
Accounts Payable	195.92	102.41	120.25	61.53	46.93	45.72
Accrued Expenses	85.36	76.44	62.92	37.31	21.18	44.92
Short-Term Debt	1,136	1,098	910.18	842.6	823.75	501.87
Current Portion of Long-Term Debt	-	-	-	21.95	58.85	64.2
Current Portion of Leases	4.36	4.81	3.66	3.13	2.6	-
Current Income Taxes Payable	48.11	60.59	53.71	33.49	18.31	19.79
Other Current Liabilities	125.62	30.67	31.23	22.05	18.71	31.19
Total Current Liabilities	1,595	1,373	1,182	1,022	990.33	707.69
Long-Term Debt	-	-	-	-	29.55	61.65
Long-Term Leases	7.31	11.7	16.34	12.26	14.81	-
Long-Term Deferred Tax Liabilities	80.03	58.23	51.56	40.5	31.06	25.96
Total Liabilities	1,683	1,443	1,250	1,075	1,066	795.29
Common Stock	378.23	375	250	250	192.15	192.15
Additional Paid-In Capital	379.9	377.7	397.52	486.97	486.97	486.97
Retained Earnings	1,146	1,022	921.68	610.87	505.79	393.61
Treasury Stock	-26.23	-26.23	-65.93	-	-	-
Comprehensive Income & Other	8.65	14.21	15.31	0.28	0.28	0.28
Total Common Equity	1,887	1,763	1,519	1,348	1,185	1,073
Minority Interest	22.45	12.94	4.59	-2.62	-1.62	-0.95
Shareholders' Equity	1,909	1,775	1,523	1,345	1,184	1,072
Total Liabilities & Equity	3,592	3,218	2,773	2,420	2,249	1,867
Total Debt	1,148	1,114	930.18	879.94	929.56	627.72
Net Cash (Debt)	-837.11	-801.18	-501.37	-397.93	-446.98	-108.9
Net Cash Per Share	-0.56	-0.53	-0.34	-0.26	-0.29	-0.07
Filing Date Shares Outstanding	1,503	1,491	1,491	1,523	1,523	1,523
Total Common Shares Outstanding	1,503	1,491	1,478	1,523	1,523	1,523
Working Capital	836.72	650.11	576.53	453.59	506.26	571.56
Book Value Per Share	1.25	1.18	1.03	0.89	0.78	0.70
Tangible Book Value	1,321	1,173	1,061	958.45	970.62	968.36
Tangible Book Value Per Share	0.88	0.79	0.72	0.63	0.64	0.64
Land	18.64	18.64	18.64	18.64	18.64	18.64
Buildings	294.77	288.43	279.17	273.34	257.23	227.84
Machinery	627.54	585.04	533.6	491.55	462.1	368.7
Construction In Progress	12.79	38.09	12.86	27.04	26.59	66.33

Source: S&P Capital IQ. Standard template. Financial Sources.